Ondine Biomedical Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 24, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	71	40	24	18	40	44
Market Cap Growth	21.37%	65.24%	39.19%	-56.51%	-8.97%	-
Enterprise Value	65.94	34.82	19.07	16.08	32.85	26.94
Last Close Price	0.14	0.09	0.09	0.09	0.21	0.56
PS Ratio	49.82	28.12	21.44	24.58	103.70	29.45
PB Ratio	37.83	21.35	6.39	14.18	5.68	2.55
P/TBV Ratio	18.35	11.57	3.55	8.41	3.46	1.49
EV/Sales Ratio	45.99	24.29	16.76	22.55	84.53	17.92
Debt / Equity Ratio	0.03	0.03	0	0.08	0.05	0.02
Net Debt / Equity Ratio	-2.91	-2.91	-1.40	-1.17	-1.05	-1.00
Net Debt / EBITDA Ratio	0.35	0.35	0.51	0.17	0.67	1.74
Net Debt / FCF Ratio	0.42	0.42	0.62	0.18	0.73	2.35
Asset Turnover	0.19	0.19	0.22	0.11	0.03	0.14
Inventory Turnover	0.67	0.67	0.62	0.42	0.30	1.80
Quick Ratio	1.02	1.02	1.73	0.95	3.41	7.81
Current Ratio	1.23	1.23	2.05	1.36	3.87	8.54
Return on Equity (ROE)	-569.77%	-569.72%	-426.09%	-209.95%	-93.81%	2401.58%
Return on Assets (ROA)	-220.32%	-220.32%	-209.57%	-132.76%	-74.00%	-95.28%
Return on Capital Employed (ROCE)	-572.82%	-572.82%	-426.36%	-198.65%	-87.51%	1195.09%
Buyback Yield / Dilution	-69.37%	-69.37%	-39.31%	-1.30%	-144.34%	-12.69%
Total Shareholder Return	-69.37%	-69.37%	-39.31%	-1.30%	-144.34%	-12.69%